Status:
ACTIVE_NOT_RECRUITING
Host-pathogen Interactions, Immune Response, and Clinical Prognosis at COVID-19 - the CoVUm Trial
Lead Sponsor:
Johan Normark
Collaborating Sponsors:
Umeå University
Region Västerbotten
Conditions:
COVID-19
Eligibility:
All Genders
15-100 years
Brief Summary
The project aims to clarify how immunity to SARS-CoV2 develops in humans and to investigate the possibility of finding patients with a particularly effective, neutralizing antibody response for future...
Detailed Description
There is currently a mounting body of evidence regarding the pathogenesis of COVID-19 caused by SARS-CoV2. By gaining more knowledge about the mechanisms in the development of viral pneumonia and the ...
Eligibility Criteria
Inclusion
- Patients between 15-100 years with SARS-CoV2 or influenza
- Patients admitted for COVID-19 or Influenza-caused pneumonia/ pneumonitis at the Departments of Infectious Diseases or ICU, Umeå University Hospital, Örebro hospital, Karlstad hospital and Västerås hospital
- Patients with COVID-19 who are treated in outpatient care at the infectious Diseases Clinic, Umeå University Hospital, Sweden
- Patients who give written informed consent to participate in the study for the entire follow- up period of 5 years.
Exclusion
- Age less than 15 years
Key Trial Info
Start Date :
April 28 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 14 2026
Estimated Enrollment :
550 Patients enrolled
Trial Details
Trial ID
NCT04368013
Start Date
April 28 2020
End Date
April 14 2026
Last Update
December 14 2023
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Incectious Diseases Clinic
Umeå, Västerbotten County, Sweden, 90189
2
Karlstad hospital
Karlstad, Sweden
3
Örebro university hospital
Örebro, Sweden
4
Västerås hospital
Västerås, Sweden